Vascular calcification--is aldosterone a culprit? (Q26851687)

E. Ritz

series ordinal

2

1 reference

J. Voelkl

series ordinal

3

1 reference

I. Alesutan

series ordinal

4

1 reference

language of work or name

1 reference

May 2013

1 reference

Nephrology Dialysis Transplantation

published in

1 reference

volume

28

1 reference

issue

5

1 reference

page(s)

1080-4

1 reference

The emerging role of phosphate in vascular calcification

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Relation between serum phosphate level and cardiovascular event rate in people with coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Phosphate: the new cholesterol? The role of the phosphate axis in non-uremic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Genetic pathways of vascular calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Nitric oxide regulates vascular calcification by interfering with TGF- signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Klotho in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Tumor necrosis factor-alpha increases alkaline phosphatase expression in vascular smooth muscle cells via MSX2 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Calcium-sensing receptor, calcimimetics, and cardiovascular calcifications in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Endogenous aldosterone is involved in vascular calcification in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Vascular calcification: pathobiological mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Vascular calcification in uremia: what is new and where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Renal phosphaturia during metabolic acidosis revisited: molecular mechanisms for decreased renal phosphate reabsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Vascular smooth muscle cell calcification and SLC20 inorganic phosphate transporters: effects of PDGF, TNF-alpha, and Pi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Plasma pyrophosphate and vascular calcification in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Klotho deficiency causes vascular calcification in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Hyperaldosteronism in Klotho-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Stanniocalcin 2 is associated with ectopic calcification in α-klotho mutant mice and inhibits hyperphosphatemia-induced calcification in aortic vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Eplerenone with valsartan effectively reduces atherosclerotic lesion by attenuation of oxidative stress and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Serum aldosterone is associated with inflammation and aortic stiffness in normotensive overweight and obese young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Effects of aldosterone on human atherosclerosis: plasma aldosterone and progression of carotid plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Participation of aldosterone in the vascular inflammatory response of spontaneously hypertensive rats: role of the NFkappaB/IkappaB system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

The emerging role of Klotho in clinical nephrology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Aldosterone regulates vascular gene transcription via oxidative stress-dependent and -independent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

The role of phosphorus in the development and progression of vascular calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Arterial calcification in patients with chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Effects of phosphate binders in moderate CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Vitamin D receptor activators inhibit vascular smooth muscle cell mineralization induced by phosphate and TNF-α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Calcific uremic arteriolopathy: pathophysiology, reactive oxygen species and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

21 January 2018

Bone-vascular cross-talk

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Aldosterone blockade: an emerging strategy for abrogating progressive renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Antifibrotic effects of aldosterone receptor blocker (spironolactone) in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Mineralocorticoid receptor blockade in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

PEARL-HF: prevention of hyperkalemia in patients with heart failure using a novel polymeric potassium binder, RLY5016.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

Plasma aldosterone concentrations in chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

7 January 2021

Mitochondrial reactive oxygen species promote p65 nuclear translocation mediating high-phosphate-induced vascular calcification in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

7 January 2021

MicroRNA-204 regulates vascular smooth muscle cell calcification in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

7 January 2021

Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

7 January 2021

Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

7 January 2021

Mineralocorticoid receptor activation promotes vascular cell calcification

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

7 January 2021

Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

7 January 2021

Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT041

7 January 2021